Intraarterial cisplatin infusion in the management of transitional cell carcinoma of the bladder
β Scribed by Stephen C. Jacobs; David S. Menashe; Mark W. Mewissen; Elliott O. Lipchik
- Publisher
- John Wiley and Sons
- Year
- 1989
- Tongue
- English
- Weight
- 411 KB
- Volume
- 64
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Loss of heterozygosity (LOH) and alterations in microsatellite DNA markers have been reported in bladder-cancer tumors. We have studied, in a blinded fashion, using PCRbased microsatellite analysis, genetic alterations of cells exfoliated in urine of 59 Caucasian patients and control patients; 31 wi
with complete responses were given an additional course of chemotherapy (intra-School of Medicine, Nagasaki, Japan. arterial cisplatin and doxorubicin) and irradiation (20 Gy), and patients with resid-
Twelve patients with primary or locally recurrent squamous carcinoma of the cervix were treated with constant internal iliac artery infusion of cisplatin (CDDP) via a totally implantable chemotherapy pump. Seven previously untreated patients received standard external and interstitial radiotherapy (